UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients

Pett, SL; McCarthy, MC; Cooper, DA; MacRae, K; Tendolkar, A; Norris, R; Strizki, JM; ... Emery, S; + view all (2009) A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients. ANTIVIRAL THERAPY , 14 (1) pp. 111-115.

Full text not available from this repository.
Type: Article
Title: A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients
Keywords: Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, Pharmacology & Pharmacy, Virology, CCR5 ANTAGONIST, MONOTHERAPY, VICRIVIROC, EFFICACY
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute for Global Health > Infection and Population Health
URI: http://discovery.ucl.ac.uk/id/eprint/1422455
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item